GET THE APP

Neutrons and the Plaque: AMI (n-8920) at Days of Zero GMA/High Ne
Clinical & Experimental Cardiology

Clinical & Experimental Cardiology
Open Access

ISSN: 2155-9880

+44 1300 500008

Research Article - (2011) Volume 2, Issue 1

Neutrons and the Plaque: AMI (n-8920) at Days of Zero GMA/High Neutron Activity (n-36) and the Following Days and Week. Kaunas, Lithuania, 2000-2007

Eliyahu G. Stoupel1,2*, Tamoshiunas A3, Radishauskas R3, Bernotiene G3, Abramson E4 and Israelevich P5
1Division of Cardiology, Rabin Medical Center, Israel
2Sackler Faculty of Medicine, Tel Aviv University, Israel
3Institute of Cardiology, Lithuania University of Medical Sciences, Kaunas, Lithuania
4Management Data Center, Rabin Medical Center, Pethah Tiqwa, Israel
5Department of Geophysics & Planetary Science, Tel Aviv University, Israel
*Corresponding Author: Eliyahu G. Stoupel, Division of Cardiology, Rabin Medical Center, Petah Tiqwa, Sackler Faculty of Medicine, Tel Aviv University, Israel, Tel: 972-97426439, Fax: 972-577-971684 Email:

Abstract

The timing and outcomes of cardiovascular diseases are linked with surrounding power fields. In recent publications it was shown that occurrence and deaths from AMI, a pathology in 3/4, or more connected with atheroma- plaque rupture or fissuring, is significantly connected with Cosmic Ray (CRA) activity, measured by Neutron activity (imp/min) on the Earth surface and inverse related to Solar (S.A.) and Geomagnetic (GMA) activity, serving as shields of the Earth from Cosmic Rays.

Aim: of this study was to check if AMI number is changing after days of Zero GMA/high Neutron activity in years 2000-2007.

Patients and Methods: 8920 AMI patients (5307, 59.5%, men) daily admissions at the departments of Cardiology of Kaunas Medical Sciences University Hospital were studied. This data was compared with daily GMA and CRA levels. We found 36 days with Zero GMA, accompanied by High CRA (Neutron) activity. AMI daily number at day of Zero GMA, 1, 2 days after the Zero day, and 7 days (including Zero day) and 6 days after (excluding Zero day) were accounted and compared with AMI on Zero day of GMA. The cosmophysical data came from Space science Institutions in the USA, Russia and Finland .

Results: the daily average for Neutrons for the whole period (2000-2007) was 8883+-518 imp/min..For days of Zero GMA 9247+-402, p<0.0001.The daily AMI on day Zero was 2.51+-1.463, n-88; next day 3.09+-1.931,n-108, (p=0.01); second day post Zero-3.09+-1.579, n-108, (p=0.008); 6 days post Zero 2.98+-0.819 daily, p=0.008 compared to Zero day). It was a 23% raise of AMI at 1 and 2 days post Zero GMA/High Neutron day and 18% rise in average at 6 days post the studied event.

Discussion: it’s presumed that high Neutron activity may be one of factors involved in the damaging process of the Coronary plaque, one of the important pathogenesis factors in AMI occurrence.

Conclusion: at6 days following Zero GMA/high Neutron (CRA) it’s a significant raise of AMI patients. Neutron activity can be involved in the process of atheroma - plaque damaging and development of Atherothrombosis and AMI, explaining observed in many studies timing of the disease.

Keywords: Neutrons; Plaque; Acute myocardial infarction; Cosmic ray; Geomagnetic activity

Introduction

In addition to recognized risk factors environmental physical factors like Solar (SA), Geomagnetic (GMA), Cosmic Ray activity (CRA), space Proton flux and other forces are involved in regulation of human homeostasis and timing of medical emergencies [1-14].

In recent years a number of studies were published in relation of CRA and their activity units-Neutron activity on the Earth’s surface (in impulses per minute-imp/min and Acute Myocardial Infarction (AMI), Stroke (CVA), Sudden Cardiac Death (SCD) timing [1-17].

Most studies find links between the ting of the mentioned cardiovascular events and the level of CRA (Neutron) activity. We know that most AMI are a consequence of atheromatous plaque in the coronary arteries disruption, or fissuring (18-34) Physical agents can be a part of the process affecting the plaque.SA and GMA are natural shields against CRA and Neutron flux, and they are inverse related [28].

The aim of this study was to explore the dynamics of AMI morbidity on days of Zero GMA AND RESPECTIVELY HIGH LEVELS OF CRANeutron activity on this day and following days of the next post Zero GMA day.

Patients and Methods

We studied the number of admissions for AMI in the departments of Cardiology (including ICCU) in the Medical Science University hospital in Kaunas, Lithuania in years 2000-2007. 8920 patients were included in the study. The diagnosis of AMI was based on the guidelines of the European Society of Cardiology, including clinical, electrocardiography, echocardiography and enzymatic (Troponin, CPC etc.) criteria [34]. Daily GMA was checked. The studied period included 36 days of Zero GMA [28]. We calculated the average number of AMI at day of Zero GMA, first and second day post the Zero day and also, including Zero GMA day and 6 days, following the Zero day for all patients with AMI and for both gender separately.

We calculated the average daily Neutron activity for the whole 2000-2007 period and separately for the Zero GMA days.

The cosmophysical data about SA, GMA, and CRA was obtained from the National Oceanic Atmospheric Administration National Geophysical Data Center and Space Weather Prediction Centers, USA, IZMIRAN Institute of the Russian Academy of Sciences and Oulu University Neutron Monitoring station in Finland [26-30].

Statistics

Statistical significance of the compared average data for Neutrons and AMI and their standard deviation at days Zero GMA and following days was calculated.

Differences (in percents) between the number of AMI patients admitted at Zero GMA and these admitted at the first and second days post Zero day and six days after the Zero day are presented.

Results

Table 1 presents AMI patients distribution on Zero GMA and one and two days after, and the following week- including the Zero day and six days after, excluding the Zero day.

  Daily St. Dev. AMI Average Average Statistical Significance of Daily Rase of AMI Post Zero GMA/High Neutron Activity Days
PARAMETERS Average   Number Male Female
  Total        
ZERO DAY 2.51 1.463 88 1.54 0.97  
             
1st DAY POST 3.09 1.931 108 1.8 1.29 Zero/1st day post p=0.01
             
2nd DAY POST 3.09 1.579 108 1.51 1.57 Zero/2nd day post p=0.0083
             
DAILY AVERAGE 2.91 0.735 102 1.64 1.28 Zero/daily average 7 days
1 WEEK,           Including Zero p=0.02
Including Zero            
DAILY AVERAGE 2.98 0.819 104.3 1.65 1.33 Zero/daily average
6 Days Post           Excluding Zero (6 days) p=0.008

Table 1: DAILY AMI (n-8920) ON DAYS (n-36) OF ZERO GMA/HIGH NEUTRON ACTIVITY AND A WEEK LATER. KAUNAS, LITHUANIA, 2000 – 2007.

Figure 1 presents the AMI admissions average daily on day Zero, first and second day and the average of 6 days following Zero GMA days. It’s also shown the difference in percents and statistical significance of average data at any of the compared days, or groups of days in ratio to number of AMI at the Zero GMA/high Neutron activity days. The daily number of AMI at days one and two post Zero rose at 23%; at six days post Zero – by 18.7% compared with the Zerohigh Neutron activity days. The difference was significant at p= 0.01- 0.008. It was also shown that the average daily Neutron activity in years 2000-2007 was 8883 +-518 imp/min. On Zero GMA days- 9247+- 402, imp/min.; p<0.0001- significantly higher at Zero GMA days. For the interrelationship between CRA (Neutron) activity and SA and GMA illustration we calculated their monthly links in the last 20 years: results are presented in Figure 2.

clinical-experimental-cardiology-Figure-1

Figure 1:

clinical-experimental-cardiology-Figure-2

Figure 2:

Discussion

AMI is one of the most often presentations of Acute Coronary Events, a solid part of cardiovascular mortality. [27,12,33,34]. Not rare a initially minimal stenosis , not providing a serious hemodynamic treat in a very short time is transformed to a complete, or subtotal coronary artery occlusion with possible sudden death ,or necrobiosis of the excluded from arterial supply part of the myocardium, as a result of acute atherothombosis. [23] The basis for this, often catastrophic event in the culprit artery of AMI are, in most cases, disruption, or fissuring of a “vulnerable” atherosclerotic plaque, with secondary elements of inflammation and artery lumen thrombosis at the surface of the damaged plaque. [13-26].

Many risk factors, like dislipidemia, high blood pressure, diabetes, obesity, smoking, deficit of physical activity predispose the plaque to grow, to become amorphous in his structure, with his lipid cup composition predisposed to disruption and/ or fissuring. [20,25,26,23]. In the last decade a number of important studies about nigh energy CRA were published [35-39]. The level of CRA is measured by Neutron activity on the Earth’s surface: they are remains of atoms crushed by CRA in the higher space. In recent years many studies demonstrated the links between timing of AMI and environmental physical activity. In a recent of publications [1-7,41,42] of our and related groups it was shown, that AMI timing is connected with CRA- Neutron activity on the Earth surface. Neutron activity is inverse related to SA and GMA [28]. SA and GMA are serving as a natural shield against CRA.

This study was provided in conditions when one of the CRA – Neutron antagonists GMA is eliminated and conditions for Neutron action (activity) is improved. In the published studies many acute cardiac events like AMI, SCD, the culprit artery of AMI; AMI complications (cardiogenic shock, right ventricular infarction), life threatening cardiac arrhythmia were inverse related to four levels of GMA and correlated with CRA (Neutron) activity [1-12,17-27]; in this study the factor of GMA was eliminated.

This, in our opinion, could help demonstrate the role of physical action of Neutrons (measured in imp/min) in the plaque damaging process close to the hours or days leading to the acute event-AMI.

The studied eight years period included only 36 days of Zero GMA. This could affect the statistical significance of the results. But nevertheless they were highly significant. Clinical data of the next 3 years, when the number of Zero days from year 2000 until the end of year 2010 is now over 115 [27] will, in the future, serve a basis for new observations. The following Zero day raise of admissions of patients with AMI is an additional confirmation of the role of Neutrons in the process of plaque damage and development of AMI. The role of neutrons in the timing of SCD, life threatening arrhythmias, atherothrombosis in the LAD artery was demonstrated in publications of the recent years. [16,17,1-4].

What can be presumed about the way of Neutron action? One of the ways accepted in biological studies of Neutron action is they affinity to hydrogen and H+ ions (high in the lipid structures), transformation Neutrons to Protons and attacking the cellular nuclei [40,41], Also Neutron action targeting cellular DNA is presumed with following cellular damage [41]. Can we prevent such effects? One of possibilities, maybe, can include some artificial magnetic devices, that high risk patients can use at days of very low GMA and high Neutron activity. Here we must take in account that high GMA is also harmful, especially rising coagulation, inflammation indices, arterial blood pressure etc. [42,43].

Before such preventive magnetic shield at periods of high CRA (Neutron) activity can be used, additional titration of the level of strength of the magnetic field must be titrated. Also patients must be informed about high Neutron activity periods. The presented data is another step exploring the links between the surrounding physical activity and human homeostasis-a subject of studies in Clinical Cosmobiology [44,45,17].

Limitations of the study

When one of antineutron powers-GMA is excluded, the SA is still acting (but is changing in the 11-year SA cycle). An ideal picture of Neutron action would be without this power also. But it’s non natural way for such situation..

We mentioned that the relatively small number of Zero GMA days is diminishing the results of this study. We’ll try to prolong our studies.

At this stage many studies about coronary plaque’s are done using intravascular ultrasound. In the future possibilities to measure the plaque “life” using different sorts of nanotechnology will allow monitoring the pre-AMI metabolism and corpuscular effects much more precisely.

Conclusion

Days of high Neutron activity on the Earth surface and Zero Geomagnetic activity are followed by significant admission raise of patients with Acute Myocardial Infarction, most on the first two days, but remaining on next to Zero six days.

The results of Neutron activity correlation with increased number of AMI serve as a basis to presume that Neutron involvement in the atheroma - plaque damage in the human coronary arteries –the basic morphologic process in the pathogenesis of this Acute Cardiac Event.

Use of antagonistic to Neutron activity physical forces (magnetic fields?) Can be considered at days of high Neutron activity in high risk population.

References

  1. Stoupel E, Israelevich P, Petrauskiene J, Kalediene R, Abramson E, et al. (2002) Cosmic ray activity and monthly number of deaths: a correlative study. J Basic & Clin Physiol Pharmacol 13: 23-32.
  2. Stoupel E, Domarkiene S, Radishauskas R, Abramson E, Israelevich P, et al. (2006) Neutrons and Sudden Cardiac Deaths (SCD) Codes 121-125 ICD 10. Basic & Clin Physiol & Pharmacol 17: 45-53.
  3. Stoupel E, Domarkiene S, Radishauskas R, Bernotiene G, Abramson E, et al. (2004) Links between monthly rates of four subtypes of acute myocardial infarction and their corresponding cosmophysical activity parameters. J Basic & Clin Physiol & Pharmacol 15: 175-184.
  4. Stoupel E, Assali A, Teplitzky I, Vaknin-Assa H, Abramson E, et al. (2009) Physical influences on right ventricular infarction and cardiogenic shock in acute myocardiaInfarction. Basic & Clin Physi Pharmacol 1: 83-90.
  5. Stoupel E, Babayev, E., Mustafa, F., Abramson, E.,Israelevich, P., Sulkes, J. Acute myocardial Infarction occurrence: Environmental links – Baku 2003-2005 data. Med Sc Monit, 2007,13(8), BR 175-179.
  6. Stoupel E, Tamoshiunas A, Radishauskas R, Bernotiene G, Abramson E, et al. (2010) Acute Myocardial Infarction and Intermediate Coronary Syndrome . Health 2: 131-136.
  7. Jansen F, Pirjola R, Favre R (2000) Space Weather Hazard to the Earth? Swiss Re Publishing, Zurich 1-40.
  8. Palmer S J, Rycroft M J, Cermack M (2006) Solar and geomagnetic activity, extremely low frequency magnetic and electric fields and human health at the Earth’s surface. Surv Geophys 27: 557–595.
  9. Kirby AJ, Hollffelder F (2008) Enzymes under the nanoscope. Nature 456: 45- 47.
  10. Stoupel E, Babayev ES, Mustafa FR, Abramson E, Israelevich P, et al. (2006) Clinical cosmobiology –sudden cardiac death and daily/ monthly geomagnetic, cosmic ray and solar activity - the Baku study (2003-2005). Sun and Geosphere 1: 13-16.
  11. Stoupel E (2006) Cardiac arrhythmia and geomagnetic activity. Indian Pacing Electrophysiol J 1: 49-53.
  12. Berger PL, Oxford JL (2006) Acute Myocardial Infarction : Eidemiology ACP Medicine. Dale DC, Federman DD (Eds.), Web MD Inc., NY.
  13. Liese AD, Hense HW, Brenner H, Löwel H, Keil U (2001) Assessing the impact of classical risk factors on myocardial infarction by rate advancement periods. Am J Epidemiol 154: 486-488.
  14. Nuzhdina MA (1998) Effect of natural factors on the occurrence of cardiovascular diseases. Biofizika 43: 640-646.
  15. Stoupel E, Kusniec J, Mazur A, Zabarsky R, Golovchiner G, et al. (2005) The time distribution of implantable cardioverter defibrillator (ICD) discharges and environmental physical activity. Pacing Clin Electrophysiol 28: 777-781.
  16. Stoupel E, Assali A, Teplitzky I, Israelevich P, Abramson E (2008) The culprit artery in acute myocardial infarction in different environmental physical activity levels. Int J Cardiology 126: 288-289.
  17. Stoupel E (2008) Atherothrombosis - Environmental Links. (2008) J Bas & Clin Physiol & Pharmacol 19: 37-47.
  18. Stoupel E, Kusniec J, Mazur J, Abramson E, Israelevich P, et al. (2008) Timing of life-.threatening arrhythmias detected by implantable cardioverter defibrillators in relation to changes in cosmophysical factors. Cardiology J 15: 1-4.
  19. V Fuster (Ed.) The Vulnerable Atherosclerotic Plaque: Understanding, Identification and Modification, American Heart Association Monograph Series, Blackwell Publishing, 1999, 429 pages.
  20. Fuster V, Fayad ZA, Badimon JJ (1999) Acute coronary syndromes: biology. Lancet 353: SII5-SII9.
  21. Goldstein JL, Brown MS (2001) Molecular Medicine: The cholesterol quartet. Science 292: 1310-1312.
  22. Libby P (2003) Vascular biology of atherosclerosis: overview and state of the art. Am J Cardiol 91: 3A-6A.
  23. E.J.Topol (Ed.) (2005) Atlas of atherothrombosis, London, Science Press 61- 86.
  24. EM Antman, E Braunwald (2005) ST-elevation myocardial infarction: Pathology, pathophysiology, and clinical features. Braunwald’s Heart Disease, 7th edition. Elsevier Saunders, Philadelphia.
  25. Gawaz M (2006) The evolving science of atherothrombotic disease Eur heart J Suppl Antiplateled Strategies in Patients Undergoing Interventions with Acute Coronary Syndrome Ed. J.-F. Neumann 10: 14-17.
  26. Solem J, Levin M, Karlsson T, Grip L, Albertsson P, et al. (2006) Composition of coronary plaque obtained by directional atherectomy instable angina: its relation to serum lipids and statin treatment. J Int Med 259: 267-275.
  27. Tanaka A, Shimada K, Numba M, Sakamoto T, Nakamura Y, et al. (2008) Relationship between longitudinal. Morphology of ruptured plaques and TIMI flow grade in acute coronary syndrome: a three-dimensional intravascular ultrasound imaging study. Eur Heart J 29: 38-44.
  28. De Catherina R, Husted S, Walentin L, Agnelli G, Bachmann F, et al. (2007) ESC position paper v. Anticoagulants in heart disease: current status and perspectives. Eur Heart J 28: 880-913.
  29. SESC Glossary of Solar-Terrestrial Terms (1988, revised 1992) NOAA-USAF Space Environment Services Center.
  30. Solar Indices Bulletin. (monthly) NOAA. National Geophysocal Data Center. Boulder, Co, USA.
  31. NOAA SWPC, US AF Preliminary Report and Forecast of Solar Geophysical Data (Weekly) Boulder, CO, USA.
  32. Moscow Neutron Monitoring Station. IZMIRAN Institute. Russian Academy of Sciences.
  33. Oulu University. Neutron Monitorig Data. Daily, Monthly. Oulu. Finland.
  34. Acute Myocardial Infarction, ICD code I21. International Statistical Classification of Diseases (ICD) and Related Health Problems 10th Revision, Version for 2007, World Health Organization, Chapter IX,
  35. Thigesen K, Alpert JS (2007) White HD on behalf the ESC/ACCF/AHA/WHF task force universal -definition of myocardial infarction. Circulation 116: 2634- 2653.
  36. Sigl G (2001) Ultrahigh energy cosmic rays: physics and astrophysics at extreme energies. Science 291: 73-79.
  37. Amelino-Camelia G (2002) Relativity: Special treatment. Nature 418: 34-35.
  38. The Pierre Auger collaboration (2007) Correlation of the Highest–Energy Cosmic Rays with Nearby Extragalactic Objects. Science 318: 938-943.
  39. Dorfman LI Cosmic Rays and Space Weather. Israel Cosmic Ray Center& Emilio Serge Observatory. (2003) Israel, IZMIRAN, Russian Academy of Sciences, Russia.
  40. Nias AHV (2000) An introduction to radiotherapy. John Wiley & Sons, NY, 1999, repr.2000.
  41. Hall E J, Giaccia AJ (2006) Radiobiology for the Radiologists. Lippincott, Williams & Wilkins. Philadelphia, Baltimore, New York, London, Buenos Aires, Hong Kong, Sydney, Tokyo
  42. Oranevskii VN, Breus TK, Baevskii RM, Rappoprt SI, Petrov VM, et al. (1998) Effect of geomagnetic activity on the functional status of the body. Biofizika 43: 819-826.
  43. Stoupel E (2002) The effect of geomagnetic activity on cardiovasculoar parameters. J Clin Basic Cardiol 56: 247s-256s.
  44. Stoupel E (1980) Solar-Terrestrial Predictions: Aspects For Preventive Medicine Solar –Terrestrial Predictions Proceedings. U.S. Department of Commerce, NOAA, USAF Environmental Research Laboratories. vol.4, G-29-G-40. Boulder, Co. USA.
  45. The Equilibrium Paradigm in Clinical Cosmobiology. (2002) J Bas Clin Physiol Pharmacol 3: 255-261.
Citation: Stoupel EG, Tamoshiunas A, Radishauskas R, Bernotiene G, Abramson E, et al. (2011) Neutrons and the Plaque: AMI (n-8920) at Days of Zero GMA/ High Neutron Activity (n-36) and the Following Days and Week. Kaunas, Lithuania, 2000-2007. J Clinic Experiment Cardiol 2:121.

Copyright: © 2011 Stoupel E, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Top